Rubino Stephen 4
4 · Viracta Therapeutics, Inc. · Filed Jun 10, 2022
Insider Transaction Report
Form 4
Rubino Stephen
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-06-09+40,000→ 40,000 totalExercise: $3.24Exp: 2032-06-09→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]1/12th of the shares subject to the option shall vest each month following the date of grant, or if earlier 100% of the shares subject to the option shall vest on the date of the Issuer's next annual stockholder meeting, in each case subject to the reporting person remaining a Service Provider (as defined in the 2021 Equity Incentive Plan) through the applicable vesting date.